TAMBE: EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Discover the GORE® TAMBE, the first FDA-approved off-the-shelf endovascular solution for treating complex aneurysmal disease of the visceral aorta.
Specifications | GORE® EXCLUDER® TAMBE - Gore Medical
Simplify your search for the right size and component of GORE® EXCLUDER TAMBE with our extensive catalogue numbers and detailed sizing specifications.
EXCLUDER® TBE approved by FDA for Breakthrough ... - Gore …
FLAGSTAFF, Ariz. (January 25, 2024) — W. L. Gore & Associates (Gore) announced FDA approval for the GORE ® EXCLUDER ® Thoracoabdominal Branch Endoprosthesis (TAMBE), …
Initial Experience With the GORE® EXCLUDER® …
The TAMBE is the first TAAA device design to be developed with a specific bridging stent-graft. Characteristics of this stent-graft include its balloon-expandable platform with the benefits of …
Study and the continued access subjects. The study design includes the assessment of the TAMBE Device in treating patients with thoracoabdominal and pararenal aortic aneurysms. A …
Total transfemoral approach for Gore Excluder thoracoabdominal …
Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE) (W. L. Gore & Associates) represents a new endovascular treatment for thoracoabdominal aneurysms. 1 TAMBE …
米国FDA批准Gore在复杂主动脉瘤中的突破性血管内装置_主动脉 …
米国Gore（公司名称）宣布，米国食品药品监督管理局 (FDA)批准了“Gore隔绝胸腹主动脉分支腔内假体” (Excluder thoracoabdominal branch endoprosthesis, TAMBE)，Gore表示， 这是第 …
Branch Endoprosthesis (TAMBE) introduces a novel concept, which is based on the GORE® EXCLUDER® AAA Device platform using a nitinol stent frame and conformable ePTFE …
GORE® EXCLUDER® 胸腹分支内置假体（TAMBE 装置） 在 腹主 …
2024年8月27日 · 使用 gore® excluder® 胸腹分支内假体（tambe 主动脉组件）的主动脉组件进行治疗，可对涉及内脏血管的主动脉疾病进行血管内修复。 签署知情同意书时年龄≥18岁。
Early outcomes from the pivotal trial of a four-branch off-the shelf ...
2024年4月13日 · Key Findings: Treatment of extent IV thoracoabdominal aortic and pararenal aneurysms using the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (TAMBE) …